Prognostication and treatment predictions for estrogen receptor positive early-stage breast cancer: incorporating the 70-gene signature into the PREDICT prognostication model.
Saved in:
| Title: | Prognostication and treatment predictions for estrogen receptor positive early-stage breast cancer: incorporating the 70-gene signature into the PREDICT prognostication model. |
|---|---|
| Authors: | Engelhardt EG; Division of Molecular Pathology, Netherlands Cancer Institute, Amsterdam, the Netherlands; Division of Psychosocial Research and Epidemiology, Netherlands Cancer Institute, Amsterdam, the Netherlands., Binuya MAE; Division of Molecular Pathology, Netherlands Cancer Institute, Amsterdam, the Netherlands; Department of Biomedical Data Sciences, Leiden University Medical Center, Leiden, the Netherlands; Department of Clinical Genetics, Leiden University Medical Center, Leiden, the Netherlands., Pharoah PDP; Department of Computational Biomedicine, Cedars-Sinai Medical Center, Los Angeles, CA, USA., Poncet C; European Organisation for Research and Treatment of Cancer Headquarters, Brussels, Belgium., Rutgers EJT; Department of Surgical Oncology, Netherlands Cancer Institute, Amsterdam, the Netherlands., Piccart M; Oncology Department, Institut Jules Bordet and l'Université Libre de Bruxelles (U.L.B.), Hôpital Universitaire de Bruxelles (HUB), Brussels, Belgium., Cardoso F; Breast Unit, Champalimaud Clinical Center, Champalimaud Foundation, Lisbon, Portugal., van 't Veer LJ; UCSF Helen Diller Family Comprehensive Cancer Center, San Francisco, CA, USA., Steyerberg EW; Department of Biomedical Data Sciences, Leiden University Medical Center, Leiden, the Netherlands., Linn SC; Division of Molecular Pathology, Netherlands Cancer Institute, Amsterdam, the Netherlands; Division of Medical Oncology, Netherlands Cancer Institute, Amsterdam, the Netherlands; Department of Pathology, University Medical Center Utrecht, Utrecht, the Netherlands., Schmidt MK; Division of Molecular Pathology, Netherlands Cancer Institute, Amsterdam, the Netherlands; Department of Clinical Genetics, Leiden University Medical Center, Leiden, the Netherlands. Electronic address: mk.schmidt@nki.nl. |
| Source: | Breast (Edinburgh, Scotland) [Breast] 2025 Oct; Vol. 83, pp. 104542. Date of Electronic Publication: 2025 Jul 19. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Elsevier Country of Publication: Netherlands NLM ID: 9213011 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1532-3080 (Electronic) Linking ISSN: 09609776 NLM ISO Abbreviation: Breast Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
| FullText | Text: Availability: 0 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 40714573 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Prognostication and treatment predictions for estrogen receptor positive early-stage breast cancer: incorporating the 70-gene signature into the PREDICT prognostication model. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Engelhardt+EG%22">Engelhardt EG</searchLink>; Division of Molecular Pathology, Netherlands Cancer Institute, Amsterdam, the Netherlands; Division of Psychosocial Research and Epidemiology, Netherlands Cancer Institute, Amsterdam, the Netherlands.<br /><searchLink fieldCode="AU" term="%22Binuya+MAE%22">Binuya MAE</searchLink>; Division of Molecular Pathology, Netherlands Cancer Institute, Amsterdam, the Netherlands; Department of Biomedical Data Sciences, Leiden University Medical Center, Leiden, the Netherlands; Department of Clinical Genetics, Leiden University Medical Center, Leiden, the Netherlands.<br /><searchLink fieldCode="AU" term="%22Pharoah+PDP%22">Pharoah PDP</searchLink>; Department of Computational Biomedicine, Cedars-Sinai Medical Center, Los Angeles, CA, USA.<br /><searchLink fieldCode="AU" term="%22Poncet+C%22">Poncet C</searchLink>; European Organisation for Research and Treatment of Cancer Headquarters, Brussels, Belgium.<br /><searchLink fieldCode="AU" term="%22Rutgers+EJT%22">Rutgers EJT</searchLink>; Department of Surgical Oncology, Netherlands Cancer Institute, Amsterdam, the Netherlands.<br /><searchLink fieldCode="AU" term="%22Piccart+M%22">Piccart M</searchLink>; Oncology Department, Institut Jules Bordet and l'Université Libre de Bruxelles (U.L.B.), Hôpital Universitaire de Bruxelles (HUB), Brussels, Belgium.<br /><searchLink fieldCode="AU" term="%22Cardoso+F%22">Cardoso F</searchLink>; Breast Unit, Champalimaud Clinical Center, Champalimaud Foundation, Lisbon, Portugal.<br /><searchLink fieldCode="AU" term="%22van+'t+Veer+LJ%22">van 't Veer LJ</searchLink>; UCSF Helen Diller Family Comprehensive Cancer Center, San Francisco, CA, USA.<br /><searchLink fieldCode="AU" term="%22Steyerberg+EW%22">Steyerberg EW</searchLink>; Department of Biomedical Data Sciences, Leiden University Medical Center, Leiden, the Netherlands.<br /><searchLink fieldCode="AU" term="%22Linn+SC%22">Linn SC</searchLink>; Division of Molecular Pathology, Netherlands Cancer Institute, Amsterdam, the Netherlands; Division of Medical Oncology, Netherlands Cancer Institute, Amsterdam, the Netherlands; Department of Pathology, University Medical Center Utrecht, Utrecht, the Netherlands.<br /><searchLink fieldCode="AU" term="%22Schmidt+MK%22">Schmidt MK</searchLink>; Division of Molecular Pathology, Netherlands Cancer Institute, Amsterdam, the Netherlands; Department of Clinical Genetics, Leiden University Medical Center, Leiden, the Netherlands. Electronic address: mk.schmidt@nki.nl. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%229213011%22">Breast (Edinburgh, Scotland)</searchLink> [Breast] 2025 Oct; Vol. 83, pp. 104542. <i>Date of Electronic Publication: </i>2025 Jul 19. – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Elsevier%22">Elsevier </searchLink><i>Country of Publication: </i>Netherlands <i>NLM ID: </i>9213011 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1532-3080 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2209609776%22">09609776 </searchLink><i>NLM ISO Abbreviation: </i>Breast <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=40714573 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1016/j.breast.2025.104542 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 104542 Titles: – TitleFull: Prognostication and treatment predictions for estrogen receptor positive early-stage breast cancer: incorporating the 70-gene signature into the PREDICT prognostication model. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Engelhardt EG – PersonEntity: Name: NameFull: Binuya MAE – PersonEntity: Name: NameFull: Pharoah PDP – PersonEntity: Name: NameFull: Poncet C – PersonEntity: Name: NameFull: Rutgers EJT – PersonEntity: Name: NameFull: Piccart M – PersonEntity: Name: NameFull: Cardoso F – PersonEntity: Name: NameFull: van 't Veer LJ – PersonEntity: Name: NameFull: Steyerberg EW – PersonEntity: Name: NameFull: Linn SC – PersonEntity: Name: NameFull: Schmidt MK IsPartOfRelationships: – BibEntity: Dates: – D: 01 M: 10 Text: 2025 Oct Type: published Y: 2025 Identifiers: – Type: issn-electronic Value: 1532-3080 Numbering: – Type: volume Value: 83 Titles: – TitleFull: Breast (Edinburgh, Scotland) Type: main |
| ResultId | 1 |
